Position in VRTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$474,225
-$290,139 QoQ
Shares Held
1,062
-37.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sigma Planning Corp holds $10,800,162 across 16 Biotechnology names. VRTX ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
7,297 | $1,669,042 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,012 | $1,554,551 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
20,592 | $1,330,860 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
61,060 | $1,328,665 | |
| 5 | MRNA |
Moderna, Inc.
|
25,705 | $1,305,814 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
4,500 | $898,425 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,062 | $474,225 | |
| 8 | RNTX |
Rein Therapeutics, Inc.
|
348,677 | $453,280 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $474,225 | 1,062 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $764,364 | 1,686 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $639,156 | 1,632 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,015,056 | 2,280 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,121,873 | 2,314 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $938,693 | 2,331 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,277,109 | 2,746 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,409,441 | 3,007 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,251,103 | 2,993 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $724,671 | 1,781 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $988,277 | 2,842 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $971,975 | 2,762 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $867,072 | 2,752 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $913,699 | 3,164 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $903,364 | 3,120 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $574,288 | 2,038 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $392,237 | 1,503 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $354,654 | 1,615 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $509,343 | 2,808 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $324,019 | 1,607 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $261,521 | 1,217 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $282,426 | 1,195 | Shares | Sole | 2021-02-09 | |
| 2020-06-30 | $2,614,531 | 9,006 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||